IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Antaki, Nabil; Bibert, Stéphanie; Kebbewar, Kamel; Asaad, Fouad; Baroudi, Osama; Alideeb, Sawsan; Hadad, Milad; Abboud, Dirar; Sabah, Houda; Bochud, Pierre-Yves; Negro, Francesco

doi:10.1136/gutjnl-2012-302019

Scientific article

English

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

ContributorsAntaki, Nabil; Bibert, Stéphanie; Kebbewar, Kamel; Asaad, Fouad; Baroudi, Osama; Alideeb, Sawsan; Hadad, Milad; Abboud, Dirar; Sabah, Houda; Bochud, Pierre-Yves; Negro, Francesco

Published inGut, vol. 61, no. 11, p. 1640-1641

Publication date2012

Keywords

Antiviral Agents/therapeutic use
Female
Hepacivirus/genetics
Hepatitis C, Chronic/drug therapy
Humans
Interleukins/genetics
Male
Polymorphism, Single Nucleotide

Affiliation

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie

Research group

Etudes et traitement de l'hépatite C et B (554)

Citation (ISO format)

ANTAKI, Nabil et al. IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5. In: Gut, 2012, vol. 61, n° 11, p. 1640–1641. doi: 10.1136/gutjnl-2012-302019

Article (Published version)

Identifiers

PID : unige:27530
DOI : 10.1136/gutjnl-2012-302019
PMID : 22345656

ISSN of the journal0017-5749

497views

0downloads

Creation03/25/2013 4:40:00 PM

First validation03/25/2013 4:40:00 PM

Update time03/14/2023 8:09:06 PM

Status update03/14/2023 8:09:06 PM

Last indexation08/29/2023 6:13:44 AM

Archive ouverte UNIGE

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Technical informations